COVID-19 vaccine-related allergies are rare, typically mild and treatable, finds study

Allergic reactions to the new mRNA-based COVID-19 vaccines are rare, typically mild and treatable, and they should not deter people from becoming vaccinated, according to research from the Stanford University School of Medicine. The findings will be published online Sept. 17 in JAMA Network Open. We wanted to understand the spectrum of allergies to the […]

Research focuses on ways to enhance gluten-free products

Gluten is a protein complex found in cereals such as wheat, rye and barley. It is responsible for the elastic texture of dough so that loaves and rolls can be baked into different shapes while remaining flexible and crusty. It also lengthens the shelf life of bread at room temperature, when associated with preservatives. Gluten […]

NCI grants more than $4.2 million to launch Cancer Epitope Database and Analysis Resource

Researchers are about to welcome a new one-stop shop for crucial information on how the immune system targets cancers. The National Cancer Institute (NCI) of the National Institutes of Health has granted over $4.2 million to launch the Cancer Epitope Database and Analysis Resource (CEDAR), led by La Jolla Institute for Immunology (LJI) Professors Alessandro […]

Check All Components in Cases of Suspected Shoe Allergy

Approximately 20% of shoe allergens are not detected with the current screening series, according to a retrospective study of more than 30,000 patients. Contact allergy to shoes remains a common but difficult problem for many reasons, including the limited information from shoe manufacturers, differences in shoe manufacturing processes, and changes in shoe trends, said Raina […]

Avomine

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. Avomine® Promethazine theoclate 25 mg tablets 30 tablet pack Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Avomine tablets. It does not contain all the available information. It does not take the place of talking […]

Effient

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. EFFIENT® Ef’-fee-ent Prasugrel hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Effient. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The […]

Cordilox SR

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CORDILOX SR® verapamil hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Cordilox SR. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. […]

Lucrin

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. LUCRIN® INJECTION Leuprorelin acetate Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some common questions about Lucrin Injection. It does not contain all the available information. It does not take the place of talking to your doctor or […]

Moxifloxacin APO

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MOXIFLOXACIN APO TABLETS Contains the active ingredient moxifloxacin (as hydrochloride monohydrate) Consumer Medicine Information   What is in this leaflet This leaflet answers some common questions about this medicine. It does not contain all the available information. It does not take the […]

Chemmart Tramadol SR

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CHEMMART TRAMADOL SR Contains the active ingredient, tramadol (as tramadol hydrochloride) Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking your medicine. This leaflet answers some common questions about tramadol. It does not contain all the available […]